Department of Paediatric Respiratory Medicine, Great Ormond Street Hospital for Children, London, UK.
Department of Paediatric Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
J Sleep Res. 2019 Oct;28(5):e12826. doi: 10.1111/jsr.12826. Epub 2019 Mar 7.
The Pediatric Sleep Questionnaire described by Chervin et al. (Sleep Medicine, 2000, 1, 21-32) was originally validated for children with obstructive sleep apnoea syndrome but without other disorders. The aim of our study was to check the applicability of this questionnaire in children with underlying chronic medical conditions. Children aged 2-18 years who underwent a diagnostic sleep study at Great Ormond Street Hospital were recruited over a 10-month period. The Pediatric Sleep Questionnaire completed by their parents and cardiorespiratory polygraphy were scored. Sensitivities and specificities of the Pediatric Sleep Questionnaire were calculated using a Pediatric Sleep Questionnaire score of 0.33 as being indicative of sleep-disordered breathing. A total of 561 patients were reviewed. Neuromuscular disorders (n = 108), craniofacial anomalies (n = 58) and the obstructive sleep apnea syndrome control group (n = 155) were best represented. The sensitivity for patients with isolated obstructive sleep apnoea syndrome was 76.5% when using an apnoea-hypopnoea index ≥ 5, but this was much lower when looking at specific sub-groups such as neuromuscular patients (25%) or patients with Trisomy 21 (36.7%). Sensitivities remained unchanged for patients with obstructive sleep apnoea syndrome (77.3%) when an apnoea-hypopnoea index of ≥ 1 was used, but improved for neuromuscular disorders sub-groups (36.7%) and Trisomy 21 (84%). In conclusion, the Pediatric Sleep Questionnaire is not a good screening tool for obstructive sleep apnoea syndrome in children with complex underlying disorders when a cut-off apnoea-hypopnoea index of ≥ 5 is used, and it cannot replace cardiorespiratory polygraphy recording.
Chervin 等人描述的儿科睡眠问卷(《睡眠医学》,2000 年,第 1 卷,21-32 页)最初是为患有阻塞性睡眠呼吸暂停综合征但无其他疾病的儿童验证的。我们的研究目的是检查该问卷在患有潜在慢性疾病的儿童中的适用性。在 10 个月的时间里,在大奥蒙德街医院接受诊断性睡眠研究的 2-18 岁儿童被招募。他们的父母填写了儿科睡眠问卷,心肺多导睡眠图进行了评分。使用儿科睡眠问卷得分为 0.33 表示睡眠呼吸障碍,计算了儿科睡眠问卷的敏感性和特异性。共回顾了 561 例患者。神经肌肉障碍(n=108)、颅面畸形(n=58)和阻塞性睡眠呼吸暂停综合征对照组(n=155)的患者人数最多。当使用呼吸暂停低通气指数≥5 时,孤立性阻塞性睡眠呼吸暂停综合征患者的敏感性为 76.5%,但在观察神经肌肉患者(25%)或 21 三体患者(36.7%)等特定亚组时,敏感性要低得多。当使用呼吸暂停低通气指数≥1 时,阻塞性睡眠呼吸暂停综合征患者的敏感性保持不变(77.3%),但神经肌肉障碍亚组(36.7%)和 21 三体(84%)的敏感性有所提高。总之,当使用≥5 的呼吸暂停低通气指数作为截断值时,儿科睡眠问卷不是一种用于患有复杂潜在疾病的儿童阻塞性睡眠呼吸暂停综合征的良好筛查工具,它不能替代心肺多导睡眠图记录。